Investing
Top 10 Analyst Upgrades & Downgrades (AMGN, COP, DD, GENZ, GS, MON, MOS, BBY, PBR, VMW)
Published:
Last Updated:
These are ten of the top impact research calls with upgrades and downgrades from Wall Street early this Friday morning:
Amgen (AMGN) Raised to Overweight at JPMorgan.
ConocoPhillips (COP) Raised to Buy at Goldman Sachs.
DuPont (DD) Started as Buy at UBS.
Genzyme (GENZ) Started as Buy at Piper Jaffray.
Goldman Sachs (GS) Started as Outperform at FBR.
Monsanto (MON) Started as Buy at UBS.
Mosaic (MOS) Started as Buy at UBS.
Best Buy (BBY) Removed from Goldman Sachs Conviction Buy List, but maintained as “Buy.”
Petrobras (PBR) Cut to Hold at Deutsche Bank.
VMware (VMW) Cut to Sell at Auriga.
JON C. OGG
March 27, 2009
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
